robert.levy

(cross posts removed by moderator--please read the Administrative Notice before you post.)

Doug London will be giving a lecture on Oct 1st, at 7 pm at the
Plymouth
library on Omega 3's and their use in treating Mental illness.

About Douglas London
Douglas London is on the faculty of medicine at Harvard Medical
School. London is a Research Associate at the Psychopharmacological
Research Laboratory at Mclean Hospital and works with Andrew Stoll,
MD, on novel treatments, particularly those that are most promising
for developing nations and populations in the US that do not have
access to traditional pharmacological medications and therapies. He
is Executive Director of BrainRights for the Americas (Mente Sana para
las Americas). He was director of the International Psychiatric Clinic
(Clinica Internacional para la Ansiedad) in Antigua, Guatemala and is
present director of the International Psychiatric Clinic in Honduras.
He has worked for 15 years in developing nations in Africa and Latin
America. London has worked for a variety of institutions including
United States government programs, the United Nations, international
non-governmental organizations and research institutions. He has
established new hospitals in the developing world such as a general
hospital in Angola, Africa, building the physical resources, training
hospital staff and administering the hospital until it was running
smoothly. London has also founded and served as director for a
research mental health clinic in Central America. He has trained
doctors and medical staff in aspects of psychopharmacology in
hospitals in Central America. London has done research in
psychopharmacology in the developing world including the use of
omega-3 fatty acids in pediatric and adult affective disorder in
Guatemala and is a pioneer in the field of agricultural psychiatry.

robert.levy

Anouncement:

Doug London will be giving a lecture on Oct 1st, at 7 pm at the
Plymouth library on Omega 3's and their use in treating Mental
illness.

Douglas S. London
Douglas London is on the faculty of medicine at Harvard Medical
School. London is a Research Associate at the Psychopharmacological
Research Laboratory at Mclean Hospital and works with Andrew Stoll,
MD, on novel treatments, particularly those that are most promising
for developing nations and populations in the US that do not have
access to traditional pharmacological medications and therapies. He
is Executive Director of BrainRights for the Americas (Mente Sana para
las Americas). He was director of the International Psychiatric Clinic
(Clinica Internacional para la Ansiedad) in Antigua, Guatemala and is
present director of the International Psychiatric Clinic in Honduras.
He has worked for 15 years in developing nations in Africa and Latin
America. London has worked for a variety of institutions including
United States government programs, the United Nations, international
non-governmental organizations and research institutions. He has
established new hospitals in the developing world such as a general
hospital in Angola, Africa, building the physical resources, training
hospital staff and administering the hospital until it was running
smoothly. London has also founded and served as director for a
research mental health clinic in Central America. He has trained
doctors and medical staff in aspects of psychopharmacology in
hospitals in Central America. London has done research in
psychopharmacology in the developing world including the use of
omega-3 fatty acids in pediatric and adult affective disorder in
Guatemala and is a pioneer in the field of agricultural psychiatry.